Oil-in-Water Nanosized Emulsions for Drug Delivery and Targeting. Tamilvanan Shunmugaperumal

Чтение книги онлайн.

СКАЧАТЬ topical ocular drug delivery: recent developments and future challenges, J. Ocul. Pharmacol., 2 (1), 67–108. doi:10.1089/jop.1986.2.67

      54 Liang, H., Brignole‐Baudouin, F., Rabinovich‐Guilatt, L. et al. (2008), Reduction of quaternary ammonium‐induced ocular surface toxicity by emulsions: an in vivo study in rabbits, Mol. Vis., 14, 204–216. http://www.molvis.org/molvis/v14/a26

      55 Liu, Y., Mounkes, L.C., Liggitt, H.D. et al. (1997), Factors influencing the efficiency of cationic liposome‐mediated intravenous gene delivery, Nat. Biotechnol., 15 (2), 167–173. doi:10.1038/nbt0297‐167

      56 Lundberg, B.B., Griffiths, G., and Hansen, H.J. (1999), Conjugation of an anti‐B‐cell lymphoma monoclonal antibody, LL2, to long‐circulating drug‐carrier lipid emulsions, J. Pharm. Pharmacol., 51, 1099–1105. doi:10.1211/0022357991776787

      57 Lundberg, B.B., Griffiths, G., and Hansen, H.J. (2004), Cellular association and cytotoxicity of anti‐CD74‐targeted lipid drug‐carriers in B lymphoma cells, J. Control. Release, 94 (1), 155–161. doi:10.1016/j.jconrel.2003.09.016

      58 Memisoglu, E., Bochot, A., Sen, M. et al. (2002), Amphiphilic β‐cyclodextrins modified on the primary face: synthesis, characterization and evaluation of their potential as novel excipients in the preparation of nanocapsules, J. Pharm. Sci., 91 (5), 1214–1224. doi:10.1002/jps.10105

      59 Midmore, B.R. (1998), Synergy between silica and polyoxyethylene surfactants in the formation of o/w emulsions, Colloids Surf. A Physicochem. Eng. Aspects, 145 (1–3), 133–143. doi:10.1016/S0927‐7757(98)00577‐9

      60 Montgomery, D.C. (2013), Design and Analysis of Experiments, 8th ed., Wiley, Hoboken, NJ; Chapter 1 (p. 3,19), Chapter 11 (p. 501), Chapter 14 (p. 605).

      61 Moolman, F.S., Rolfes, H., van der Merwe, S.W. et al. (2004), Optimization of perfluorocarbon emulsion properties for enhancing oxygen mass transfer in a bio‐artificial liver support system, Biochem. Eng. J., 19 (3), 237–250. doi:10.1016/j.bej.2004.02.003

      62 Motwani, S.K., Copra, S. Talegaonkar, S. et al. (2008), Chitosan‐sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimization and in vitro characterization, J. Pharm. Biopharm., 68 (3), 513–525. doi:10.1016/j.ejpb.2007.09.009

      63 Muchtar, S. and Benita, S. (1994), Emulsions as drug carriers for ophthalmic use, Colloid Surf. A Physicochem. Eng. Aspects, 91 (3), 181–190. doi:10.1016/0927‐7757(94)02882‐6

      64 Müllar, R.H. (1990), Colloidal Carriers for Controlled Drug Delivery and Targeting: Modification, Characterization and In Vivo Distribution, Wiss Verl‐Ges, Stuttgart, Germany.

      65 Müller, R.H. and Schmidt, S. (2002). SolEmuls technology for i.v. emulsions of poorly soluble drugs: amphotericin B, in: Fourth World Meeting on Pharamceutics, Biopharmaceutics and Pharmaceutical Technology, Florence, pp. 1451–1452.

      66 Nakajima, M., Nabetani, H., Ichikawa, S. et al. (2003), Functional emulsions, US Patent 6538019.

      67  Naskar, M.K., Patra, A., and Chatterjee, M. (2006), Understanding the role of surfactants on the preparation of ZnS nanocrystals, J. Colloid Interface Sci., 297 (1), 271–275. doi:10.1016/j.jcis.2005.10.057

      68 Negi, P., Singh, B., Sharma, G. et al. (2015), Biocompatible lidocaine and prilocaine loaded‐nanosized emulsion system for enhanced percutaneous absorption: QbD‐based optimisation, dermatokinetics and in vivo evaluation, J. Microencapsul., 32 (5), 419–431. doi:10.3109/02652048.2015.104651

      69 Nobs, L., Buchegger, F., Gurny, R. et al. (2004), Current methods for attaching targeting ligands to liposomes and nanoparticles, J. Pharm. Sci., 93 (8), 1980–1992. doi:10.1002/jps.20098

      70 Ogawa, S., Decker, E.A., and McClements, D.J. (2003), Production and characterization of o/w emulsions containing cationic droplets stabilized by lecithin‐chitosan membranes, J. Agric. Food Chem., 51 (9), 2606–2812. doi:10.1021/jf020590f

      71 Orloff, J.J. (2011), The promise and threat of quality risk management, Pharm. Technol., 35 (2), 38–40.

      72 Pickering, S.U. (1907), Emulsions, J. Chem. Soc., 91, 2001–2021. doi:10.1039/CT9079102001

      73 Pongcharoenkiat, N., Narsimhan, G., Lyons, R.T. et al. (2002), The effect of surface charge and partition coefficient on the chemical stability of solutes in o/w emulsions, J. Pharm. Sci., 91 (2), 559–570. doi:10.1002/jps.10064

      74 Puri, D., Khatik, G.L., and Tamilvanan, S. (2019), Studies on olive‐and silicone‐oils‐based Janus macroemulsions containing ginger to manage primary dysmenorrheal pain, Mater. Sci. Eng. C Mater. Biol. Appl., 100, 276–285. doi:10.1016/j.msec.2019.01.137

      75 Q8(R2) (2009), ICH harmonized tripartite guideline for pharmaceutical development, current step 4 version, (Accessed on August 1, 2019).

      76 Simberg, D., Weisman, S., Talmon, Y. et al. (2003), The role of organ vascularization and lipoplex‐serum initial contact in intravenous murine lipofection, J. Biol. Chem., 278, 39858–39865. doi:10.1074/jbc.M302232200

      77 Simovic, S. and Prestidge, C.A. (2003), Adsorption of hydrophobic silica nanoparticles at the PDMS droplet‐water interface, Langmuir, 19, 8364–8370. doi:10.1021/la0347197

      78 Simovic, S. and Prestidge, C.A. (2007), Nanoparticle layers controlling drug release from emulsions, Eur. J. Pharm. Biopharm., 67 (1), 39–47. doi:10.1016/j.ejpb.2007.01.011

      79 Simovic, S. and Prestidge, C.A. (2008), Colloidosomes from controlled interaction of submicrometer triglyseride droplets and hydrophilic silica nanoparticles, Langmuir, 24, 7132–7137. doi:10.1021/la800862v

      80 Song, Y.K., Liu, D., and Maruyama, K.Z. (1996), Antibody mediated lung targeting of long‐circulating emulsions, PDA J. Pharm. Sci. Technol., 50 (6), 372–377.

      81 Sonne, M.R. (2015), Tocopherol compositions for delivery of biologically active agents, in: USPTO Patent full‐text and image database no. 6,193,985, Dumex, Copenhagen, pp. 1–21.

      82 Solans, C., Izquierdo, P., Nolla, J. et al. (2005), Nano‐emulsions, Curr. Opin. Colloid Interface Sci., 10 (3–4), 102–110. doi:10.1016/j.cocis.2005.06.004

      83 Swietlikowska, D.W. and Sznitowska, M. (2006), Partitioning of parabens between phases of submicron emulsions stabilized with egg lecithin, Int. J. Pharm., 312 (1–2), 174–178. doi:10.1016/j.ijpharm.2006.01.005

      84 Sznitowska, M., Janicki, S., Dabrowska, E.A. et al. (2002), Physicochemical screening of antimicrobial agents as potential preservatives for submicron emulsions, Eur. J. Pharm. Sci., 15 (5), 489–495. doi:10.1016/s0928‐0987(02)00034‐9

      85  Tadros, T. (2006), Principles of emulsion stabilization with special reference to polymeric surfactants, J. Cosmet. Sci., 57, 153–169.

      86 Tadros, T., Vandamme, A., Levecke, B. et al. (2004), Stabilization of emulsions using polymeric surfactants based on inulin, Adv. Colloid Interf. Sci., 108–109, 207–226. doi:10.1016/j.cis.2003.10.024

      87 Tambe, D.E. and Sharma, M.M. (1993), Factors controlling the stability of colloid‐stabilized emulsions: I. an experimental investigation, J. Colloid Interface Sci., 157, 244–253. doi:10.1006/jcis.1993.1182

      88 Tamilvanan, S. (2004), Oil‐in‐water lipid emulsions: implications for parenteral and ocular delivering systems, Prog. Lipid Res., 43 (6), 489–533. doi:10.1016/j.plipres.2004.09.001

      89 Tamilvanan, СКАЧАТЬ